Stock Track | Omnicell Soars 10.95% in Pre-Market on Strong Q1 Earnings Beat and Raised Full-Year Guidance

Stock Track

Apr 28

Omnicell's stock surged 10.95% during pre-market trading on Tuesday, following the release of its first-quarter 2026 financial results that significantly exceeded analyst expectations.

The healthcare technology provider reported quarterly adjusted earnings of $0.55 per share, beating the consensus estimate of $0.32 by a substantial margin. Revenue for the quarter reached $310 million, representing a 15% year-over-year increase and surpassing analyst forecasts. The company also reported a turnaround to GAAP net income of $11 million, compared to a net loss in the same period last year.

Driving the positive sentiment, Omnicell raised its full-year 2026 guidance, now expecting adjusted EPS in the range of $1.80 to $2.00, compared to previous FactSet estimates of $1.78. The company attributed its strong performance to robust demand for connected devices, disciplined cost management, and growing customer engagement with its Titan XT and OmniSphere platforms.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1161164909"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1161164909\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1161164909?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-28 19:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1161164909","market":"sg","top_or_hot":-1,"title":"Stock Track | Omnicell Soars 10.95% in Pre-Market on Strong Q1 Earnings Beat and Raised Full-Year Guidance","media":"Stock Track","content":"<p>Omnicell's stock surged 10.95% during pre-market trading on Tuesday, following the release of its first-quarter 2026 financial results that significantly exceeded analyst expectations.</p><p>The healthcare technology provider reported quarterly adjusted earnings of $0.55 per share, beating the consensus estimate of $0.32 by a substantial margin. Revenue for the quarter reached $310 million, representing a 15% year-over-year increase and surpassing analyst forecasts. The company also reported a turnaround to GAAP net income of $11 million, compared to a net loss in the same period last year.</p><p>Driving the positive sentiment, Omnicell raised its full-year 2026 guidance, now expecting adjusted EPS in the range of $1.80 to $2.00, compared to previous FactSet estimates of $1.78. The company attributed its strong performance to robust demand for connected devices, disciplined cost management, and growing customer engagement with its Titan XT and OmniSphere platforms.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Omnicell Soars 10.95% in Pre-Market on Strong Q1 Earnings Beat and Raised Full-Year Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Omnicell Soars 10.95% in Pre-Market on Strong Q1 Earnings Beat and Raised Full-Year Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-28 19:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Omnicell's stock surged 10.95% during pre-market trading on Tuesday, following the release of its first-quarter 2026 financial results that significantly exceeded analyst expectations.</p><p>The healthcare technology provider reported quarterly adjusted earnings of $0.55 per share, beating the consensus estimate of $0.32 by a substantial margin. Revenue for the quarter reached $310 million, representing a 15% year-over-year increase and surpassing analyst forecasts. The company also reported a turnaround to GAAP net income of $11 million, compared to a net loss in the same period last year.</p><p>Driving the positive sentiment, Omnicell raised its full-year 2026 guidance, now expecting adjusted EPS in the range of $1.80 to $2.00, compared to previous FactSet estimates of $1.78. The company attributed its strong performance to robust demand for connected devices, disciplined cost management, and growing customer engagement with its Titan XT and OmniSphere platforms.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OMCL","symbol_name":"Omnicell","start_time":0,"source_url":"","article_id":"1161164909","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1161164909","pubTimestamp":1777374294,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Omnicell's stock surged 10.95% during pre-market trading on Tuesday, following the release of its first-quarter 2026 financial results that significantly exceeded analyst expectations.The healthcare...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OMCL":"Omnicell"},"translate_title":"个股追踪|Omnicell盘前飙升10.95%，因Q1盈利强劲，并上调全年指引","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OMCL":1},"content_text":"Omnicell's stock surged 10.95% during pre-market trading on Tuesday, following the release of its first-quarter 2026 financial results that significantly exceeded analyst expectations.The healthcare technology provider reported quarterly adjusted earnings of $0.55 per share, beating the consensus estimate of $0.32 by a substantial margin. Revenue for the quarter reached $310 million, representing a 15% year-over-year increase and surpassing analyst forecasts. The company also reported a turnaround to GAAP net income of $11 million, compared to a net loss in the same period last year.Driving the positive sentiment, Omnicell raised its full-year 2026 guidance, now expecting adjusted EPS in the range of $1.80 to $2.00, compared to previous FactSet estimates of $1.78. The company attributed its strong performance to robust demand for connected devices, disciplined cost management, and growing customer engagement with its Titan XT and OmniSphere platforms.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}